Teladoc Health, Inc. (NYSE:TDOC) Shares Bought by Summit Trail Advisors LLC

Summit Trail Advisors LLC lifted its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 77.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,978 shares of the health services provider’s stock after purchasing an additional 7,819 shares during the period. Summit Trail Advisors LLC’s holdings in Teladoc Health were worth $143,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Wedmont Private Capital lifted its holdings in Teladoc Health by 20.3% in the 1st quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider’s stock worth $117,000 after buying an additional 2,715 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Teladoc Health by 18.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock worth $22,213,000 after acquiring an additional 384,528 shares in the last quarter. Geode Capital Management LLC grew its stake in Teladoc Health by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock valued at $35,894,000 after purchasing an additional 22,664 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in Teladoc Health by 22.1% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider’s stock worth $134,000 after purchasing an additional 2,662 shares during the last quarter. Finally, Commonwealth Equity Services LLC raised its position in shares of Teladoc Health by 35.7% in the 4th quarter. Commonwealth Equity Services LLC now owns 113,563 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 29,903 shares in the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Teladoc Health

In related news, insider Fernando M. Rodrigues sold 4,174 shares of the firm’s stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total transaction of $28,842.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Carlos Nueno sold 3,958 shares of the company’s stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $27,151.88. Following the completion of the sale, the insider directly owned 17,645 shares of the company’s stock, valued at $121,044.70. The trade was a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 18,656 shares of company stock valued at $128,189. Corporate insiders own 0.58% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a report on Thursday, May 1st. Canaccord Genuity Group decreased their price target on Teladoc Health from $14.00 to $12.00 and set a “buy” rating for the company in a research note on Thursday, May 1st. Jefferies Financial Group lowered their price objective on Teladoc Health from $10.00 to $8.00 and set a “hold” rating for the company in a report on Monday, April 21st. Stifel Nicolaus lowered their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, May 1st. Finally, Wells Fargo & Company lowered their target price on shares of Teladoc Health from $10.00 to $8.00 and set an “equal weight” rating for the company in a research note on Thursday, May 8th. Twelve investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $9.60.

Teladoc Health Stock Performance

TDOC opened at $8.24 on Friday. The business has a 50 day moving average price of $7.31 and a two-hundred day moving average price of $8.71. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.68 and a quick ratio of 1.64. The company has a market capitalization of $1.44 billion, a price-to-earnings ratio of -1.39 and a beta of 1.84. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.